植物类中药成分治疗骨质疏松症的研究进展OA
Research progress on plant-based components of Chinese medicinals in the treatment of osteo-porosis
骨质疏松症(OP)是一种慢性退行性骨骼疾病,预后较差且恢复有限.临床上常用的双膦酸盐和激素替代疗法效果有限,且伴有显著副作用.近年来,源自中药的天然草药成分在OP治疗中引起了广泛关注.中药治疗OP的机制主要分为促进骨生成和抑制骨流失两大方面.文章通过归纳文献,重点分析了中药单一有效成分(如生物碱、类黄酮、萜类、酚类和多糖)及其总提取物的药理学分子机制,并探讨了这些成分在未来临床应用中的潜力.此外,基于成分-靶点的预测,文章总结了对OP治疗有积极意义的植物类中药,为新药开发提供参考.
Osteoporosis(OP)is a chronic degenerative bone disease with poor prognosis and limited recovery.Current clinical treat-ments,such as bisphosphonates and hormone replacement therapy,have limited efficacy and are often accompanied by significant side effects.In recent years,natural herbal components derived from Chinese medicinals(CMs)have garnered increasing attention for the treatment of OP.The mechanisms of CMs in treating OP can be broadly divided into promoting osteogenesis and inhibiting bone resorp-tion.This review focuses on analyzing the pharmacological molecular mechanisms of individual active compounds from CMs,such as alkaloids,flavonoids,terpenoids,phenols,and polysaccharides,as well as their total extracts,and explores their potential for future clinical applications.Additionally,based on component-target predictions,this paper summarizes CMs of plant origin that show promis-ing effects in the treatment of OP,providing references for new drug development.
邓杰;徐西林;任可名
黑龙江中医药大学,黑龙江 哈尔滨 150040黑龙江中医药大学附属第三医院,黑龙江 哈尔滨 150036天津中医药大学第一附属医院,中医国家临床医学研究中心,天津 300381
医药卫生
骨质疏松症植物药骨生成骨代谢
OsteoporosisPlant-based Chinese medicinalsOsteogenesisBone metabolism
《时珍国医国药》 2026 (16)
3195-3200,6
国家自然科学基金(82374496)黑龙江省自然科学基金(PL2025H254)黑龙江省重点研发计划(GZ20210136,GA21C006)黑龙江省中医药科研项目(ZHY2023-099)黑龙江省骨坏死基础与临床研究重点实验室项目黑龙江省教科文卫体系统"劳模和工匠人才创新工作室"项目(徐西林创新工作室[2024]22号)
评论